Altitude sickness epidemiology and demographics
|
Altitude sickness Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Altitude sickness epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Altitude sickness epidemiology and demographics |
|
Risk calculators and risk factors for Altitude sickness epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
With a rapid ascend to high altitude in 1 to 3 days, more than 50% of people develop altitude sickness. The incidence of clinical HAPE in unacclimatized travelers exposed to high altitude (~ 4,000 m) appears to be less than 1%. In over 30 years of research experience, the U.S. Army Pike's Peak Research Laboratory, utilizing about 300 sea-level resident volunteers (and more than 100 staff members) rapidly and directly exposed to high altitude, only 3 were evacuated with suspected HAPE.